- Home
- GNW vs CORT Comparison
GNW vs CORT Comparison
Compare GNW & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GNW | CORT |
|---|---|---|
| Founded | 1871 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | 2004 | 2001 |
Fundamental Metrics
Financial Performance| Metric | GNW | CORT |
|---|---|---|
| Price | $8.86 | $83.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $10.50 | ★ $96.50 |
| AVG Volume (30 Days) | ★ 2.4M | 1.0M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $7,301,000,000.00 | $761,407,000.00 |
| Revenue This Year | N/A | $26.08 |
| Revenue Next Year | N/A | $26.98 |
| P/E Ratio | $74.42 | ★ N/A |
| Revenue Growth | 0.08 | ★ 12.79 |
| 52 Week Low | $6.75 | $28.66 |
| 52 Week High | $9.45 | $91.00 |
Technical Indicators
Market Signals| Indicator | GNW | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 53.13 | 87.17 |
| Support Level | $8.01 | $68.20 |
| Resistance Level | $9.21 | $90.00 |
| Average True Range (ATR) | 0.18 | 3.11 |
| MACD | 0.01 | 0.95 |
| Stochastic Oscillator | 61.08 | 100.00 |
Price Performance
Historical ComparisonAbout GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has four main operating business segments: Enact, Closed Block segment, and Corporate and Other. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. The majority of the revenue is generated by the Enact segment. The company earns the maximum of its revenue in the United States.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.